Department of Neurology, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
J Neuroimmunol. 2011 Oct 28;239(1-2):61-7. doi: 10.1016/j.jneuroim.2011.08.015. Epub 2011 Oct 5.
Dysfunction of the blood-brain barrier (BBB) and blood-spinal cord barrier (BSCB) is a primary characteristic of multiple sclerosis (MS). We evaluated the protective effects of fasudil, a selective ROCK inhibitor, in a model of experimental autoimmune encephalomyelitis (EAE) that was induced by guinea-pig spinal cord. In addition, we studied the effects of fasudil on BBB and BSCB permeability. We found that fasudil partly alleviated EAE-dependent damage by decreasing BBB and BSCB permeability. These results provide rationale for the development of selective inhibitors of Rho kinase as a novel therapy for MS.
血脑屏障 (BBB) 和血脊髓屏障 (BSCB) 的功能障碍是多发性硬化症 (MS) 的主要特征。我们评估了 Rho 激酶选择性抑制剂法舒地尔在豚鼠脊髓诱导的实验性自身免疫性脑脊髓炎 (EAE) 模型中的保护作用,并研究了法舒地尔对 BBB 和 BSCB 通透性的影响。我们发现法舒地尔通过降低 BBB 和 BSCB 通透性,部分缓解了 EAE 依赖性损伤。这些结果为开发 Rho 激酶选择性抑制剂作为 MS 的一种新疗法提供了依据。